Ontology highlight
ABSTRACT:
SUBMITTER: Lee J
PROVIDER: S-EPMC9962369 | biostudies-literature | 2023 Feb
REPOSITORIES: biostudies-literature
Journal of clinical medicine 20230215 4
Triple-negative breast cancer (TNBC) accounts for 15-20% of all breast cancers and is characterized by an aggressive nature and a high rate of recurrence despite neoadjuvant and adjuvant chemotherapy. Although novel agents are constantly being introduced for the treatment of breast cancer, conventional cytotoxic chemotherapy based on anthracyclines and taxanes is the mainstay treatment option for TNBC. Based on CTNeoBC pooled analysis data, the achievement of pathologic CR (pCR) in TNBC is direc ...[more]